We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Breaks Out Rules for OTC, Rx Blood Glucose Test Systems
FDA Breaks Out Rules for OTC, Rx Blood Glucose Test Systems
The FDA Tuesday laid out separate requirements for 510(k)s for over-the-counter and prescription point-of-care blood glucose tests — a shift from current guidance that applies to all blood glucose monitoring systems.